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Protocol
AbstrACt
Introduction Potential predictors of poor outcome will 
be measured at baseline: (1) preoperatively to develop 
a clinical prediction model to predict which patients are 
likely to have favourable outcome following lumbar spinal 
fusion surgery (LSFS) and (2) postoperatively to predict 
which patients are likely to have favourable long-term 
outcomes (to inform rehabilitation).
Methods and analysis Prospective observational study 
with a defined episode inception of the point of surgery. 
Electronic data will be collected through the British 
Spine Registry and will include patient-reported outcome 
measures (eg, Fear-Avoidance Beliefs Questionnaire) and 
data items (eg, smoking status). Consecutive patients 
(≥18 years) undergoing LSFS for back and/or leg pain 
of degenerative cause will be recruited. Exclusion 
criteria: LSFS for spinal fracture, inflammatory disease, 
malignancy, infection, deformity and revision surgery. 1000 
participants will be recruited (n=600 prediction model 
development, n=400 internal validation derived model; 
planning 10 events per candidate prognostic factor). The 
outcome being predicted is an individual’s absolute risk of 
poor outcome (disability and pain) at 6 weeks (objective 
1) and 12 months postsurgery (objective 2). Disability and 
pain will be measured using the Oswestry Disability Index 
(ODI), and severity of pain in the previous week with a 
Numerical Rating Scale (NRS 0–10), respectively. Good 
outcome is defined as a change of 1.7 on the NRS for 
pain, and a change of 14.3 on the ODI. Both linear and 
logistic (to dichotomise outcome into low and high risk) 
multivariable regression models will be fitted and mean 
differences or ORs for each candidate predictive factor 
reported. Internal validation of the derived model will 
use a further set of British Spine Registry data. External 
validation will be geographical using two spinal registries 
in The Netherlands and Switzerland.
Ethics and dissemination Ethical approval (University of 
Birmingham ERN_17-0446A). Dissemination through peer-
reviewed journals and conferences.
IntroduCtIon 
surgery
The recent UK National Institute for Health 
and Care Excellence (NICE) guideline1 is 
unequivocal in its recommendation regarding 
lumbar spinal fusion surgery (LSFS). It states 
that LSFS should not be offered for patients 
strengths and limitations of this study
 ► This study will enable predictions to be made re-
garding lumbar spinal fusion surgery and rehabili-
tation based on the risk of poor outcome following 
surgery.
 ► The study design is informed by the Transparent 
Reporting of a multivariable prediction model for 
Individual Prognosis Or Diagnosis TRIPOD statement 
of items that should be included in reports of predic-
tion model development and validation to ensure a 
rigorous methodology.
 ► A sample of n=1000 participants will ensure ad-
equate power in the analyses (n=600 prediction 
model development, n=400 internal validation of 
derived model; planning 10 events per candidate 
prognostic factor).
 ► Statistical modelling has been planned a priori.
 ► Future implementation of the derived models will 
enable targeting surgical and rehabilitation resourc-
es at patients with the greatest clinical need and 
potential benefit.
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with non-specific low back pain (NSLBP) unless LSFS 
is being investigated as part of a randomised controlled 
trial (RCT). This is coupled with a key research recom-
mendation to investigate whether patients with NSLBP 
should be offered LSFS as an option for management. 
The NICE recommendation is noteworthy as LSFS is 
currently a common and increasingly used procedure 
aiming to decompress and stabilise the lumbar spine 
in degenerative presentations that encompass spinal 
stenosis, disc herniation, discogenic low back pain (exam-
ples of NSLBP1) and spondylolisthesis (an example of 
specific LBP).2–4 Momentarily, the primary indication for 
LSFS is chronic back and/or leg pain, of degenerative or 
spondylolisthetic cause, resistant to conservative manage-
ment; where it can potentially stabilise the spine.5 There 
are three aims of surgical intervention: (1) to stabilise a 
level(s) of the spine thought to be the pain generator, (2) 
to stabilise the spine at the same time as performing a 
lumbar decompression for radicular or stenotic leg pain 
where the decompression will potentially destabilise the 
spine or (3) a combination of aims 1 and 2.
In the UK, spinal surgery is the greatest single compo-
nent of expenditure for managing LBP,6 with approx-
imately 4500 LSFS procedures each year7; although 
accurate National Health Service (NHS) data are difficult 
to ascertain with 73 000 procedures recorded as ‘other 
operations on the spine’. Based on current data,7 a 65% 
increase in LSFS over 13 years, costs the NHS £26 million 
annually. US data illustrate a substantial increase in 
hospitalisation for LSFS from 61 000 in 1993 to 451 000 in 
20128 with an accompanying increase in national costs for 
LSFS from US$4.3 to US$33.9 billion between 1998 and 
2008.9 LSFS accounted for 14% of USA spending on back 
surgery in 1992, increasing to 47% by 2003.10 An ageing 
population and surgical advancements (including anaes-
thetic advancements making surgery possible for elderly 
persons) contribute to a continued increase.11
However, data do reveal considerable regional varia-
tion in fusion rates within and between countries.10 This 
may reflect poor surgeon consensus and/or a range of 
indications for surgery; consistent with a survey from the 
Netherlands which found a lack of consensus between 62 
surgeons regarding both prognostic factors and predictive 
tests for patient selection for LSFS.5 This contributes to a 
broad clinical heterogeneity of patients undergoing LSFS. 
In addition, our survey of UK current practice identified 
variation by surgeons regarding surgery. For example, the 
surgical procedure can include open or minimally inva-
sive procedures, be instrumented or non-instrumented, 
employ different approaches, for example, transforam-
inal and fuse different numbers of levels,12 dependent on 
indications for surgery.
The NICE guidelines1 report their analysis of nine 
studies investigating clinical effectiveness of LSFS (vs 
usual care, conservative intervention and different 
surgery). An overall low/very low level of evidence does 
not demonstrate effectiveness of LSFS but does suggest 
modest benefit in some elements of pain, function and 
quality of life and utilisation of healthcare resources. 
However, only one RCT was found comparing LSFS to 
usual care and the included studies were extended to 
cohort studies and other comparators. In a follow-up of 
three RCTs13 that compared LSFS to multidisciplinary 
cognitive–behavioural and exercise rehabilitation, no 
difference in patient-reported outcomes was found. Risk 
of bias was high across all studies (eg, large cross over 
bias, no data regarding interventions prior to LSFS were 
recorded). The guidelines call for an adequately powered 
multicentre RCT. However, planning for a future RCT 
first needs to address the clinical heterogeneity of this 
population, something that is acknowledged in the guide-
lines in that some patients responded positively to surgery 
with large treatment effects, thus supporting the value of 
being able to predict response to LSFS.
rehabilitation
There is minimal knowledge regarding long-term 
outcome,6 although one recent paper13 found that after 
a mean of 11 years (range 8–15 years) follow-up across 
three RCTs, there was no difference between LSFS and 
multidisciplinary cognitive–behavioural therapy and 
exercise (mean-adjusted treatment effect was −0.7 points 
on the 0–100 Oswestry Disability Index (ODI)). Data from 
the Swedish National Spine Register revealed that 17% 
of their patients had no change or worsened back and/
or leg pain following surgery and 28% were not satisfied 
regarding their outcome at 12 months.14 A high revision 
rate (>200 per year, in the UK7; and 13% rehospitalisation 
rate USA15) post-LSFS is also reported and is perhaps a 
sign of overutilisation. Rehabilitation (outpatient active 
rehabilitation programmes as distinct to normal recovery) 
following LSFS has also therefore been a focus within the 
literature. Two recent systematic reviews16 17 identified 
three trials that provide inconclusive, very low-quality 
evidence for the effectiveness of physiotherapy rehabilita-
tion following LSFS. Our initial evaluations of current UK 
practice identified extensive variability in referral to and 
content of physiotherapy intervention due to the clinical 
heterogeneity of the LSFS population both presurgery 
and postsurgery.12 18 A key conclusion from the surveys 
was therefore that rehabilitation should be tailored to the 
individual patient.12 18
Key issue
The current evidence highlights a number of problems 
and a key underlying issue is the clinical heterogeneity 
of the LSFS population; making selection of patients for 
surgery, nature of the surgical procedure, selection of 
patients for rehabilitation and nature of intervention (eg, 
patients with a poor predicted outcome may require an 
early and more intensive intervention following surgery) 
key considerations. Stratified management involves 
targeting treatment to subgroups of patients based on 
their key characteristics, such as predictive factors of 
outcome, in order to support decision-making to maxi-
mise treatment benefit, reduce harm, and increase 
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healthcare efficiency and cost-effectiveness. Probability 
estimates are frequently based on combining data from 
multiple predictors to ensure reliable estimates of prog-
nostic probabilities or risks19 into multivariable (risk) 
prediction models. Such models are mathematical equa-
tions that enable association of multiple predictors for an 
individual patient to their probability (or risk) of poor 
outcome.19
objectives
Potential predictors of good outcome will be measured 
at baseline preoperatively to develop a clinical prediction 
model to predict:
1. Which patients are likely to have a favourable outcome 
following LSFS,
and potential predictors of good outcome will be 
measured at baseline postoperatively to develop a clinical 
prediction model to predict:
2. Which patients are likely to have favourable long-term 
outcomes following LSFS (to inform rehabilitation).
MEthods And AnAlysIs
source of data
Prospective observational study with a defined episode 
inception of the point of surgery. The prospective design 
enables optimal measurement of predictors and outcome 
and control of unwarranted influences. Objective 1 inves-
tigating which patients should receive LSFS requires the 
development of a prediction model where the predic-
tors are collected preoperatively and the outcomes of 
interest postoperatively. Objective 2 investigating which 
patients who received LSFS have a poor long-term 
outcome requires the development of a prediction model 
where the predictors are collected postsurgery and the 
outcomes at long-term follow-up. This protocol is written 
in line with the TRIPOD statement of items that should 
be included in reports of prediction model development 
and validation.20
For objective 1, data will be collected electronically at 
baseline (preoperatively) and outcome will be assessed at 
6 weeks postsurgery (to inform selection of patients for 
surgery). For objective 2, data will be collected electron-
ically at baseline (6 weeks postoperatively) and outcome 
will be assessed at 12 months (to inform selection of 
patients for rehabilitation). Procedures are in place to 
enable data collection in the UK through the British 
Spine Registry (BSR) (degenerative pathway lumbar 
region), recruiting participants from January 2018 for 
approximately 24 months.
The BSR was launched in 2012 with the British Asso-
ciation of Spine Surgeons as the data controller. The 
database allows all UK spinal surgeons to record informa-
tion about patient diagnosis, comorbidities (eg, smoking 
status), surgical procedures, complications, patient-re-
ported outcome measures (PROMs) and patient-re-
ported experience measures. The BSR aims to be a 
‘whole practice’ registry covering lumbar degenerative, 
cervical degenerative, deformity, tumour, trauma, infec-
tion and intradural. The PROMs in the lumbar degen-
erative pathway are back and leg Numerical Rating Scale 
(NRS), ODI and the EuroQOL five dimensions question-
naire 5 level (ED-5D 5L). Questionnaires can be entered 
manually if completed on paper or electronically by 
patients through kiosks in clinic or email link. PROMs 
are completed before surgery and at 6 weeks, 6 months, 
1 year, 2 years and 5 years after surgery. Reminders will 
be used to maximise completeness of data, in the form 
of electronic reminders generated by the registry on two 
occasions at each data collection point; with one SMS and 
one personal telephone reminder if required. Anony-
mised data will be downloaded from the BSR into SPSS 
V.22 and stored securely at the University of Birmingham 
in line with research governance procedures for a period 
of 10 years. Data will be checked for completeness. The 
PROMs data are completed by the patients and surgical 
data by the surgeon or a member of the clinical team. 
General Medical Council requirements for probity are 
likely to keep data accurate.
Participants
Eligibility criteria:
 ► Inclusion criteria: Adult patients (≥18 years) under-
going LSFS for back pain and/or leg pain of degen-
erative cause.
 ► Exclusion criteria: LSFS for spinal fracture, inflam-
matory disease, malignancy, infection, deformity and 
revision fusion surgery.
Patients will be recruited through the BSR. All patients 
who are booked in for LSFS for degenerative reasons will 
be invited to participate and enter their data into the 
registry. All consecutive eligible patients will therefore 
be approached for recruitment into the study. Based on 
feasibility data, it is estimated that 70 eligible participants 
will be available for recruitment in a 1-month period. 
Their surgeons will be invited to enter the surgical data 
when the procedure is complete. Registry data represent 
approximately 500 spinal surgeons in the UK at the start 
of data collection. Patients will be asked to provide sepa-
rate consent through the BSR for an extended data set to 
be completed for this study.
outcome
The outcome being predicted by the prediction model is 
an individual’s absolute risk of poor outcome (disability 
and pain). Outcome will be measured at 6 weeks postsur-
gery (objective 1) and 12 months postsurgery (objective 
2). Disability will be measured using the ODI—a widely 
used and validated questionnaire to assess people with 
low back pain.21 Pain will be measured using severity of 
pain in the previous week with a NRS 0–10.
Predictors
The factors identified in our recent systematic review 
as being potentially indicative of poor outcome (manu-
script under review), and factors identified from surveys 
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of surgeons and physiotherapists12 18 will be measured at 
baseline.
These include factors collected from the patient:
 ► Age.
 ► Gender.
 ► Height and weight to obtain body mass index (BMI).
 ► Education (individual to each country and 
dichotomise).
 ► Smoking status.
 ► Duration of symptoms prior to surgery.
 ► Previous surgery.
 ► ODI.
 ► NRS (0–10) back pain (mean pain previous week).
 ► NRS (0–10) leg pain (mean pain previous week).
 ► Analgesia use (dichotomous scale yes/no, frequency 
of use, name of analgesia).
 ► Distribution of pain (embedded pain drawing).
 ► EQ5D-5L.
 ► Current work status/days postsurgery when returned 
to work/normal function.
 ► Pain self-efficacy— two items (items 49 and 50) from 
the Coping Strategies Questionnaire.
 ► Pain Catastrophizing Scale .
 ► Fear-Avoidance Beliefs Questionnaire.
 ► Preoperative walking capacity—estimated in metres.
 ► Global rating of symptom change.
Also factors collected from the surgeon:
 ► Indication for surgery (focused to degenerative 
cause).
 ► Number of levels fused.
 ► Surgical approach.
 ► Surgical complications.
Demographic factors and details of the operation will 
also be collected as our survey suggested that some factors 
(eg, number of levels fused) may be risk factors and are 
included above.12
sample size
In predictive modelling a larger sample size enables lower 
bias and variance, and permits the prospective prediction 
of new observations.22 Data will be collected for an esti-
mated n=1000 participants (initial n=600 for prediction 
model development and the next n=400 for internal vali-
dation of the derived model; with about 10 events per 
candidate prognostic factor)23 24 post-LSFS.
Methodological quality in the prediction model
Limited research has identified criteria for quality in a 
prediction model, but authors have identified potential 
quality issues to ensure methodological rigour.25 All issues 
have been addressed/planned for in this study (table 1).
Patient and public involvement
This study is coproduced by patients and healthcare 
professionals. It was conceived directly as a result of 
patients’ comments to the study team regarding their 
experience of LSFS. Patients have been involved since 
inception of this programme of research starting >5 
years ago and have contributed to our understanding of 
the findings from the systematic reviews informing this 
application. Coauthor NRH leads the Centre of Preci-
sion Rehabilitation for Spinal Pain’s Patient and Public 
Involvement group. A lay summary of the study report 
will be written for patients in collaboration with the 
group and disseminated through charities (eg, backcare), 
patient groups (eg, pain support groups) and online fora 
(eg, www. painsupport. co. uk) to raise awareness of the 
study and future research plans.
statistical methods and management of missing data
The characteristics of the participants (demographics, 
clinical features, predictors) will be reported, with clarity 
of the number of participants with missing data for either 
outcome or predictors. A diagram will illustrate the flow 
of participants through the study, including the number 
of participants with and without the outcome, and 
capturing all time points. The correlation between candi-
date predictive factors will be calculated at baseline.
Statistical modelling has been planned a priori. To 
explore the influence of each predictive factor on poor 
outcome, both linear and logistic (to dichotomise the 
outcome score into low and high risk for the stratifica-
tion tool) multivariable regression models will be fitted 
and mean differences or ORs including their 95% CIs 
for each candidate predictive factor reported. If neces-
sary, multiple imputation26 will be used to deal with 
missing data. The characteristics of those patients with 
and without predictor and/or outcome data will also be 
compared, to inform whether patients with no predictor 
and/or outcome data were missing completely at random 
or not. Multivariable analysis will initially include all candi-
date predictive factors, and full results reported. Reduced 
multivariable analyses will be considered if necessary (eg, 
removing one of two candidate predictive factors that 
were highly correlated at baseline), to examine robust-
ness of conclusions. Selection of items for the model will 
include those factors which are statistically significantly 
(p<0.05) associated with poor outcome according to the 
full multivariable regression analysis using backward step-
wise selection,20 and those deemed clinically important 
to retain (regardless of statistical significance) to improve 
face validity for clinicians. The regression model with 
included predictive factors will be fitted to the cohort 
data to obtain a final set of parameter estimates (ie, alpha 
and beta terms) to form the model.
risk groups
Good outcome is based on the best current evidence 
regarding change scores and the largest study to date.27 
It is defined as a change of 1.7 on the NRS for pain, and a 
change of 14.3 on the ODI.27
development versus validation
For validation of the models, a comparison with the devel-
opment data will enable analysis of the distribution of 
important variables; inclusive of demographic, predictor 
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and outcome variables. Internal validation of the derived 
model will use a further set of BSR patient data (n=400) not 
used in the development process.28 External validation of 
the model will be geographical in nature and will use two 
further sets of patient data from similar spinal registries in 
The Netherlands and Switzerland. Validation will provide 
estimates of the ability of the model to discriminate between 
patients with different outcomes as well as the agreement 
between the observed and predicted risks (calibration).
dIsCussIon
Study data will be used to develop and internally vali-
date two clinical prediction models to inform clinical 
Table 1 Methodological decisions to improve quality in prediction models
Criteria25 Methodological decisions to improve quality
Study design
  Inception cohort  ► Clear description of population.
 ► Clear description of the participants at baseline.
  Source population  ► Clear description of population.
 ► Clear description of sampling frame and recruitment (method and 
timing).
  Inclusion and exclusion criteria  ► Clarity of eligibility criteria.
  Prospective design  ► Clarity of study design.
Study attrition
  No of drop-outs  ► Adequate participation rate.
 ► Clear description of attempts to collect information on participants who 
dropped out.
 ► Reporting numbers and reasons for loss to follow-up.
  Information provided on method of 
management of missing data
 ► Appropriate methods of imputation of missing data.
Predictive factors
  All predictive factors described used to develop 
the model
 ► Clear definition of predictive factors.
 ► An adequate proportion of participants has completed data for the 
predictive factor.
  Standardised or valid measurements  ► The measurement of the predictive factor is reliable and valid.
 ► The measurement of the predictive factor is the same for all participants.
  Linearity assumption studied  ► Linearity of data will be reported.
  No dichotomisation of predictive variables  ► Continuous variables will be reported.
  Data presentation all predictive factors  ► Complete data will be presented.
Outcome measures
  Description of outcome measures  ► The outcome is clearly defined.
  Standardised or valid measurements  ► The measurement of the outcome is reliable and valid.
 ► The measurement of the outcome is the same for all participants.
  Data presentation of most important outcome 
measures
 ► Complete data will be presented.
Analysis
  Presentation of univariate crude estimates  ► An appropriate strategy for model building is described.
 ► An adequate statistical model described.
  Sufficient numbers of subjects per variable  ► Adequate data will be presented.
  Selection method of variables explained  ► Sufficient data will be presented to enable assessment of the adequacy 
of the analytic strategy.
 ► All results will be reported.
  Presentation of multivariate estimates  ► An appropriate strategy for model building is described.
 ► An adequate statistical model described.
Clinical performance/validity
  Clinical performance  ► Clinical performance of the model will be reported.
  Internal validation  ► Internal validation will be reported.
  External validation  ► Geographical external validation will be reported.
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decision-making. First, about which patients are likely 
to have a favourable outcome following LSFS to inform 
selection of patients for surgery. Second, about which 
patients are likely to have favourable long-term outcomes 
following LSFS to inform selection of patients for rehabil-
itation and nature of intervention, for example, patients 
with a poor predicted outcome may require an early 
and more intensive intervention following surgery. An 
important requirement of the prediction model is that it 
should be brief to facilitate use in clinical practice. Thus, 
we will look to simplify the model where possible to facili-
tate its use, but without important reduction in its predic-
tive ability in terms of calibration and discrimination. For 
example, if multi-item questionnaire scores are included 
in the model, then we will evaluate whether just one of 
the questionnaire questions is sufficient. This process will 
result in ideal full and simplified models if possible.
Data will be collected in parallel to this study in The 
Netherlands and Switzerland using this same protocol 
to enable external validation of the prediction models. 
Procedures are already in place to enable data collec-
tion through the Dutch Spine Registry and Swiss Spine 
Registry.
Implications of results
This study will enable predictions to be made regarding 
surgery and rehabilitation based on the risk of poor 
outcome following surgery. The resulting estimates of risk 
will be used to inform clinical decision-making regarding 
LSFS and rehabilitation interventions in line with guide-
lines,1 and future research investigating effectiveness of 
surgical and rehabilitation interventions. Future imple-
mentation of the models will enable targeting surgical 
and rehabilitation resources at patients with the greatest 
clinical need and potential benefit. This will therefore 
enable improved effectiveness (clinical and cost) as it will 
identify which patients to target with surgery, and post-
LSFS which patients to target with rehabilitation.
EthICs And dIssEMInAtIon
Findings will be disseminated through peer-reviewed 
journals and conferences.
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